All regulatory updates
718 results found
Illinois HB5046 introduced to amend 720 ILCS 570/311.6 on e-prescribing exceptions and pharmacy transfer/notification when initial e-prescription cannot be filled
Illinois HB5046 (104th General Assembly) was introduced on 2026-02-10 and proposes amendments impacting 720 ILCS 570/311.6 (electronic prescribing for Schedule II–V controlled substances). As described in the bill text, it would (1) require a dispenser/pharmacy that cannot fill an initial electronically received prescription due to out-of-stock conditions to immediately contact the patient and ask whether the prescription should be electronically transferred to a pharmacy of the patient’s choosing (consistent with 21 CFR 1306), and (2) expand/clarify exceptions to mandatory electronic prescribing where drugs may need to be filled outside typical retail hours or are difficult to obtain due to drug shortages/inventory limitations. The bill also contains conforming changes to the Pharmacy Practice Act (225 ILCS 85/19). Compliance teams at pharmacies, health systems, and prescriber organizations should monitor this bill because it would change operational workflows for patient communication and prescription transfer, and would adjust when non-electronic prescribing is permitted for controlled substances.
Illinois HB5046 introduced to amend 720 ILCS 570/311.6 on e-prescribing exceptions and pharmacy actions when initial e-prescription cannot be filled
HB5046 was introduced to amend the Illinois Controlled Substances Act provisions on electronic prescribing (720 ILCS 570/311.6). As introduced, it would add requirements for dispensers when an initial controlled-substance prescription received electronically cannot be filled due to lack of stock (including immediate patient contact and an option to transfer electronically to another pharmacy), and it would clarify/expand circumstances where prescribers are not required to issue controlled-substance prescriptions electronically (e.g., drug shortages/inventory limitations and timing constraints). Compliance teams should track bill progress and assess impacts to EPCS workflows, patient notification procedures, and pharmacy transfer processes.
CARB opens SB 261 public docket for voluntary climate-related financial risk report submissions (submission window through July 1, 2026)
CARB created/maintains a public-facing docket to accept voluntary submissions related to SB 261 climate-related financial risk reports while enforcement of the statutory requirement is enjoined. The docket provides instructions for submitting a company statement and a public URL to the report hosted on the company’s website, and it specifies a submission window of December 1, 2025 through July 1, 2026. This matters for compliance teams because it establishes a CARB intake mechanism and timing expectations for entities choosing to report during the injunction period, and it provides a central location for CARB-referenced support materials (e.g., enforcement advisory, checklist/FAQ) and for tracking what peers are submitting.
CARB opens SB 261 public docket for voluntary report link submissions (submission window shown through July 1, 2026)
CARB established and maintains a dedicated SB 261 public docket to accept voluntary submissions during the injunction period. The docket describes what entities should submit (a company statement and a public link to the SB 261 climate-related financial risk report hosted on the company website) and notes CARB’s review process prior to public posting. Operationally, this creates the mechanism CARB expects for voluntary submissions while enforcement is paused, and it displays a submission window through July 1, 2026.
CARB maintains public listing of voluntary SB 261 submissions via approved-comments docket endpoint
CARB provides a publicly accessible 'approved comments' listing for the SB 261 docket that functions as the public-facing repository of voluntary submissions while enforcement is enjoined. This listing supports compliance transparency by showing submitted materials and reinforcing the expectation that entities host their reports publicly and provide CARB the link/statement for docketing.
CARB updates SB 261 docket page (Updated 2/10/26) detailing voluntary submission mechanics and docket window
CARB updated its SB 261 public docket page (marked Updated 2/10/26) to restate its current operational posture during the injunction period and to provide practical instructions for voluntary submissions (e.g., submitting a company statement and a public link to the SB 261 report hosted on the entity’s website). The page also describes administrative handling, including an indicated review timeline before public release and a stated docket submission window (Dec 1, 2025 to Jul 1, 2026). This update is operationally important for entities choosing to submit voluntarily while enforcement is stayed.
CARB maintains SB 261 voluntary reporting docket with submission window (Dec 1, 2025–Jul 1, 2026) and process details (page updated Feb 10, 2026)
CARB’s SB 261 public docket page (updated Feb. 10, 2026) operationalizes voluntary submissions of SB 261 climate-related financial risk report links and related materials while enforcement is enjoined. The page specifies a submission window from Dec. 1, 2025 through Jul. 1, 2026, and describes process mechanics (e.g., report must be posted on the entity’s own website and submitted via link; CARB review period before public posting). For compliance teams, this provides a CARB-supported pathway to publish and log SB 261 reports voluntarily and clarifies timing/processing expectations during the injunction period.
DDS mandates use of Provider Directory for new vendorization applications; Purchase Reimbursement (Service Code 024) must use Provider Directory starting July 1, 2026
California DDS is implementing a standardized vendorization intake workflow via its Provider Directory portal. DDS states that, starting March 1, 2026, regional centers must use the Provider Directory for new vendorizations. DDS also specifies a phased requirement for Purchase Reimbursement (Service Code 024): applications may be handled manually through June 30, 2026, but effective July 1, 2026, Service Code 024 vendorization applications must be completed in the Provider Directory. Compliance teams supporting California regional centers and vendors should update internal intake procedures, training, and documentation to ensure submissions occur through the Provider Directory by the mandatory dates, particularly for Service Code 024.
CARB maintains SB 261 voluntary reporting docket and instructions while enforcement is enjoined (page updated Feb. 10, 2026)
CARB’s SB 261 docket page was updated (noted as Updated 2/10/26) and continues to provide operational instructions for covered entities that voluntarily submit climate-related financial risk reports while SB 261 enforcement is paused due to a Ninth Circuit injunction. The docket materials describe how to submit a report link/attestation, review/processing timelines, and where approved submissions are posted. Compliance teams should treat this as the current CARB-endorsed process for voluntary submissions and monitoring of SB 261 implementation posture pending litigation outcomes.
AICIS varies an AIIC listing following revocation of confidential business information (CBI) approval for CAS 403656-24-6
AICIS published an Inventory notice indicating a variation to an Australian Inventory of Industrial Chemicals (AIIC) listing due to revocation of a confidential business information (CBI) approval, identifying the affected substance by CAS 403656-24-6. For compliance teams, this signals that public inventory record content/identifiers associated with the listing may have changed following the CBI decision, which can affect substance identification, documentation, and downstream compliance communications. (Detailed notice text could not be extracted in the research run, but the official hub and notice URL corroborate the event and CAS number.)
Nevada Board of Pharmacy agenda posts workshop materials for proposed Schedule I additions: N‑pyrrolidino metonitazene and N‑pyrrolidino protonitazene (NAC 453.510)
The Nevada State Board of Pharmacy posted a first amended agenda (posted Feb 10, 2026) for its March 5, 2026 meeting that includes a workshop item and embedded proposed regulatory text to amend NAC 453.510 (Schedule I) to add the nitazene analogs N‑pyrrolidino metonitazene and N‑pyrrolidino protonitazene. If adopted through the Board’s rulemaking process, these substances would be treated as Schedule I controlled substances in Nevada, triggering associated controlled-substance controls (e.g., prohibitions/limitations on possession and handling, and compliance program updates for registrants).
Illinois HB5046 introduced to modify electronic prescribing of controlled substances requirements (out-of-stock transfer workflow and expanded exceptions)
Illinois HB5046 (104th General Assembly) was introduced to amend 720 ILCS 570/311.6 (electronic prescribing of Schedule II–V controlled substances). As described in the research text, the proposal would require a dispenser/pharmacy that cannot fill an initially received electronic controlled-substance prescription due to being out of stock to immediately contact the patient and offer to electronically transfer the prescription to a pharmacy of the patient’s choosing (consistent with 21 CFR 1306). It would also add/clarify exceptions where a prescriber is not required to e-prescribe when timely access is impractical, including when filling may need to occur outside typical retail pharmacy hours or when drug shortages/inventory limitations apply. Compliance impact: pharmacy workflow changes, patient notification/transfer procedures, and prescriber documentation/decisioning around EPCS exceptions.
CARB updates SB 261 voluntary reporting docket page (updated 2026-02-10) with submission window and instructions during injunction
CARB updated its “Climate-Related Financial Risk Reports (SB 261) Docket” page (noted as updated 2/10/26) that operationalizes voluntary SB 261 report submissions while enforcement is enjoined. The page provides submission mechanics (e.g., submit a company statement and a public URL to the SB 261 report hosted on the company’s website), states CARB will review submissions for quality/completeness prior to public posting, and displays a submission window on the page (“Deadline for Submittals - Dec 1, 2025 to Jul 1, 2026”). For compliance teams, this creates an official CARB intake/public posting pathway and a clear voluntary submission deadline window to track even during the injunction period.
AICIS publishes enforceable undertaking with MCo Beauty Pty Ltd (commenced 9 February 2026) regarding unauthorised industrial chemical introductions
AICIS published an enforceable undertaking with MCo Beauty Pty Ltd, commencing 9 February 2026. The undertaking relates to alleged unauthorised introductions of products containing industrial chemicals under the Industrial Chemicals Act 2019 framework. Commitments include quarantining relevant products (including where import volumes exceeded 100 kg in a registration year) pending destruction or re-export with evidence to AICIS within specified timeframes, and implementing documented compliance systems to prevent recurrence and ensure compliance with authorised introduction categories and related obligations. This signals AICIS enforcement expectations around introduction authorisation and internal compliance controls.
EPA proposes updates to incorporated voluntary consensus standards for TSCA Title VI formaldehyde emissions standards (incl. adding ISO 12460-2:2024 QC test method)
EPA issued a proposed rule to update the incorporation by reference (IBR) of multiple voluntary consensus standards in 40 CFR Part 770 (TSCA Title VI—Formaldehyde Emission Standards for Composite Wood Products). EPA also proposes adding ISO 12460-2:2024(en) as an additional small-scale quality control chamber test method and making related conforming updates (e.g., scope/definitions). Compliance teams in composite wood products and downstream supply chains should review whether current QA/QC testing methods and referenced standards would need updating if the rule is finalized, and should consider submitting comments to the docket by the stated deadline (March 13, 2026).
EPA final rule adds sodium perfluorohexanesulfonate (PFHxS‑Na) to TRI as a PFAS chemical of special concern (100 lb threshold); reporting starts 2026 with first reports due July 1, 2027
US EPA finalized a TRI rule adding sodium perfluorohexanesulfonate (PFHxS‑Na) to the Toxics Release Inventory as a PFAS chemical of special concern. Facilities subject to TRI must begin tracking releases and other reportable waste management quantities for PFHxS‑Na for the reporting period beginning January 1, 2026. The first Form R submissions covering PFHxS‑Na will be due July 1, 2027. The rule applies a 100 lb reporting threshold as a chemical of special concern, increasing compliance and data management obligations for TRI reporters handling PFHxS‑Na.
EPA publishes ‘year one’ roundup of PFAS actions highlighting ongoing regulatory and enforcement initiatives
EPA issued a public roundup summarizing major PFAS actions taken during the first year of the current administration, including coordination and continued emphasis on regulatory and enforcement activities addressing PFAS risks. While the release is programmatic rather than a discrete rule text amendment, it can inform compliance teams about EPA priorities, active PFAS initiatives, and likely areas of near-term regulatory attention.
EPA opens public comment on proposed updates to TSCA Title VI formaldehyde emission standards for composite wood products (new QC test method and updated referenced standards)
EPA released a proposed rule under TSCA Title VI (Formaldehyde Emission Standards for Composite Wood Products) to add a new quality control (QC) test method (including ISO 12460-2:2024(en) as referenced in the EPA materials) and make technical updates to incorporated voluntary consensus standards. The proposal is open for public comment via docket EPA-HQ-OPPT-2017-0245. Compliance teams in composite wood products and downstream product supply chains should track potential changes to acceptable QC testing methods and referenced standards used for demonstrating conformity.
EPA publishes “year one” roundup of PFAS actions highlighting ongoing regulatory and enforcement initiatives
EPA issued a news release summarizing major PFAS actions taken during the first year of the administration, signaling continued cross-program PFAS priorities (e.g., regulatory actions, implementation efforts, and enforcement posture). While not itself a binding legal change, this roundup can influence compliance planning by indicating areas of anticipated scrutiny and policy direction.
EPA proposes updates to TSCA Title VI formaldehyde emission standards for composite wood products (new QC test method and updated incorporated standards)
EPA issued a proposed rule to amend the Formaldehyde Emission Standards for Composite Wood Products regulations under TSCA Title VI by adding a new quality control test method (ISO 12460-2:2024(en) small-scale chamber method) and making technical updates to incorporated voluntary consensus standards. Compliance teams in the composite wood products supply chain should review the proposed updates to referenced standards/test methods and submit comments within the stated comment period once published in the Federal Register.